Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00228540 · ClinicalTrials.gov registry record · Phase 3
Study to Assess Satisfaction With Modafinil Treatment in Children and Adolescents With ADHD
A Phase 3 study of ADHD, sponsored by Cephalon.
- Completed
- Registry status
- Phase 3
- Development phase
- 20
- Study locations
NCT00228540: Completed Phase 3 study of ADHD, sponsored by Cephalon.
NCT00228540 is a Phase 3 study of ADHD that has completed, run by Cephalon. The trial reports 20 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00228540, a Phase 3 study of ADHD, has completed, sponsored by Cephalon.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 20
- Study locations
Study Summary
An 8-week, Open-Label Study to Characterize the Response to Modafinil (85mg Film-Coated Tablet) Treatment at Dosages up to 425mg/Day in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD) (With an Open-Ended Extension Period)
Conditions Studied
Interventions
- DRUG Modafinil
Study Locations (20)
Florida
- Sarkis Clinical Trials - Gainesville
- Clinical Neuroscience Solution - Jacksonville
- Clinical Neurosciences - Orlando
- Laszlo J. Mate, MD, PA - West Palm Beach
California
- UCI Child Development Center - Irvine
- Pharmacology Research Institut - Northridge
- Pacific Sleep Medicine Service - San Diego
Georgia
- Northwest Behavioral Research - Marietta
- Pediatrics and Adolescent - Woodstock
Illinois
- Loyola University Medical Center Department of Psychiatry - Maywood
- HALP Clinic and ADHD Research - Northbrook
Kentucky
- Michael J. Rieser, MD - Lexington
- Pedia Research, LLC - Owensboro
Louisiana
- Louisiana Research Associates - New Orleans
- Psycopharmacology Research - LSU Health Science Center - Shreveport
Michigan
- Odyssey Research - Dearborn
- Hurley Medical Center - Flint
Arizona
- Melmed Center - Scottsdale
Trial Details
| Field | Value |
|---|---|
| Start Date | 2005-09 |
| Est. Completion | 2006-09 |
| Phase | Phase 3 |
What the finished NCT00228540 record still lists
NCT00228540 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 1 condition, with ADHD appearing as the primary indexed condition, and to 1 intervention - of which Modafinil is the first listed.
NCT00228540 names 20 study sites across 10 states, led by Florida, California, Georgia.
Frequently Asked Questions
What is clinical trial NCT00228540 about?
NCT00228540 is a clinical study titled "Study to Assess Satisfaction With Modafinil Treatment in Children and Adolescents With ADHD". An 8-week, Open-Label Study to Characterize the Response to Modafinil (85mg Film-Coated Tablet) Treatment at Dosages up to 425mg/Day in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD) (With an Open-Ended Extension Period)
What is the current status of trial NCT00228540?
This trial is currently completed. It is a Phase 3 study. The study started on 2005-09. Estimated completion is 2006-09.
What conditions does trial NCT00228540 study?
This clinical trial studies the following conditions: ADHD.
What interventions are being tested in trial NCT00228540?
The interventions under investigation include: Modafinil (DRUG).
Who is sponsoring clinical trial NCT00228540?
This trial is sponsored by Cephalon, which has 64 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00228540 being conducted?
This trial has 20 study locations across Arizona, California, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for ADHD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety
RECRUITING · Phase 3
-
Treating Parents with ADHD and Their Young Children Via Telehealth: a Hybrid Type I Effectiveness-Implementation Trial
ACTIVE NOT RECRUITING · Phase 3
-
Smoking Cessation for Adults With Attention Deficit Hyperactivity Disorder (ADHD)
COMPLETED · Phase 3
-
Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD
COMPLETED · Phase 3
-
PRC-063 Adult Laboratory Classroom Study in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
COMPLETED · Phase 3
-
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia